As of today, Ottobock SE & Co. KG (ISIN: DE000BCK2223) is listed in the Prime Standard of the Frankfurt Stock Exchange. The first price of the share was 72.00 euros. The current share price is available on boerse-frankfurt.com.

BNP Paribas, Deutsche Bank and Goldman Sachs Bank Europe were accompanying the IPO as Joint Global Coordinators and Joint Bookrunners. Bank of America Securities and UBS Investment Bank acted as Senior Joint Bookrunners, and Jefferies and UniCredit were additional Joint Bookrunners. Commerzbank was Senior Co-Lead Manager. DZ Bank and LBBW were Co-Lead Manager. Lilja & Co. acted as Financial Advisor to Näder Holding and Ottobock. The designated sponsor in Xetra trading is Baader Bank. The specialist on the trading venue Börse Frankfurt is Baader Bank.

According to its own information, Ottobock is a medical technology company operating globally in the field of bionics. Its core business areas include prosthetics, orthotics, and exoskeletons. Founded in 1919, the company generated revenue of €1.43 billion last year with a global workforce of almost 9,300 employees and reported an adjusted operating profit (EBITDA) of €321million.

Further information can be found in our primary market statistics.

Media contact:
Carola Dürer
+49 69 21114739
media-relations@deutsche-boerse.com

Martin Möhring
+49 69 21116277
media-relations@deutsche-boerse.com